Drs. Laia Alemany, Mireia Martín Satué, Jordi Guiu and Gabriel Capellá will carry out their research projects in sexual and reproductive health thanks to the funds raised by La Marató 2023.
The Marató 3Cat finances three IDIBELL projects in sexual and reproductive health Read More »
A study by IDIBELL, ICO and IARC has linked the levels of certain inflammatory molecules with mortality in breast cancer patients.
The study, published in the British Journal of Cancer, included 1538 women from eight countries belonging to the EPIC cohort and diagnosed with breast cancer.
Researchers identify inflammatory markers related to the prognosis of breast cancer Read More »
The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to ADmit Therapeutics, Barcelona, Spain based on results of a recent on-site inspection as part of the CAP’s Accreditation Programs. Recognized for rigorous and robust standards, CAP accreditation elevates quality and mitigates risk, an important way that laboratories can contribute to improved
Admit therapeutics receives accreditation from college of american pathologists Read More »
The project aims to find a cure for a lethal degenerative genetic disease that affects children, adrenoleukodystrophy.
Aurora Pujol receives funding from the CaixaResearch call for Health Research 2024 Read More »
Researchers from IDIBELL and the UB show that the levels of a certain neuronal receptor are increased only in patients with a slow progression of this pathology.
Researchers identify a potential biomarker of Parkinson’s disease progression Read More »
200 researchers and teaching staff have attended the ninth edition of the PhD Day, organized annually by the Committee of Predoctoral Researchers in collaboration with other IDIBELL units. This year’s conference focused on the use of artificial intelligence in research, with a workshop and a round table on the subject.
Dr. Gascón thanked the tireless effort of the Niemann-Pick Foundation to
promote research as a tool to improve patients' quality of life.
Efavirenz is an antiretroviral drug used in HIV treatment that improves the
function of an enzyme that regulates cholesterol.
A new study by IDIBELL and Bellvitge University Hospital, published in the journal Bone, reveals that some bariatric surgeries can have an impact on bone health, especially in the hip area.
The Innovation and Health Biocluster presents itself as a key alliance to position L’Hospitalet in research and advanced medicine.
Two recent studies led by the GRIN-IDIBELL Nursing Research Group show the impact of the number of nurses and the complexity of care on complications associated with the peripheral venous catheter of patients treated in hospitalization and emergencies.
